Syndax Pharmaceuticals, Inc. (SNDX) cash on hand

Cash · fiscal 2025
$394.07M

Syndax Pharmaceuticals, Inc. (SNDX) held cash of $394.07M at the end of fiscal 2025 (December 31, 2025). That is 31.2% lower than the $572.88M of fiscal 2024. Figures as of 18 Nov 2026, 10:46 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Cash, fiscal 2025
$394.07M
Change on fiscal 2024
−31.2%
Highest on record
$572.88Mfiscal 2024
Lowest on record
$394.07Mfiscal 2025
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Syndax Pharmaceuticals, Inc. cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $572.88M in fiscal 2024 and the lowest $394.07M in fiscal 2025.

History · 4 fiscal years

Cash by fiscal year

Syndax Pharmaceuticals, Inc. cash on hand, year by year

Syndax Pharmaceuticals, Inc. (SNDX) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$394.07M 31.2% down
2024$572.88M 0.4% up
2023$570.70M 19.9% up
2022$475.80M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

More on SNDX

Syndax Pharmaceuticals, Inc., figure by figure

Syndax Pharmaceuticals, Inc. (SNDX) overview: price, valuation and scorecard

Syndax Pharmaceuticals, Inc. cash on hand: questions and answers

How much cash does Syndax Pharmaceuticals, Inc. have?

Syndax Pharmaceuticals, Inc. (SNDX) held cash of $394.07M at the end of fiscal 2025 (December 31, 2025). That is 31.2% lower than the $572.88M of fiscal 2024.

What are the highest and lowest cash figures on record for Syndax Pharmaceuticals, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was $572.88M in fiscal 2024 and the lowest $394.07M in fiscal 2025.

How is Syndax Pharmaceuticals, Inc.'s cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone. For Syndax Pharmaceuticals, Inc. it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Syndax Pharmaceuticals, Inc. (SNDX) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/SNDX/cash

Underlying data: the company's filings with the SEC and Yahoo Finance.